CHAMPIONS ONCOLOGY, INC. Increase (Decrease) in Restricted Cash for Operating Activities
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Increase (Decrease) in Restricted Cash for Operating Activities of $150.00 thousand for the 12-month period ending 2012-04-30, per its 10-K filed 2012-07-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities · last filed 2012-07-18
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2012-04-30 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2012-01-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2011-04-30 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2011-01-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for operating activities for fiscal 2012 was $150.00K.
- CHAMPIONS ONCOLOGY, INC. increase (decrease) in restricted cash for operating activities for fiscal 2011 was $0.00.
| Period end | Increase (Decrease) in Restricted Cash for Operating Activities 3 month | Increase (Decrease) in Restricted Cash for Operating Activities 6 month | Increase (Decrease) in Restricted Cash for Operating Activities 9 month | Increase (Decrease) in Restricted Cash for Operating Activities 12 month |
|---|---|---|---|---|
| 2012-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-18 | $0.00 derived: sum of 2 quarters · filed 2012-07-18 | $150.00K 10-K · filed 2012-07-18 | |
| 2012-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-14 | $150.00K 10-Q · filed 2012-03-14 | ||
| 2011-10-31 | $150.00K 10-Q · filed 2011-12-14 | |||
| 2011-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-18 | $0.00 derived: sum of 2 quarters · filed 2012-07-18 | $0.00 10-K · filed 2012-07-18 | |
| 2011-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-14 | $0.00 10-Q · filed 2012-03-14 | ||
| 2010-10-31 | $0.00 10-Q · filed 2011-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |